Provisions under House and Senate versions of prescription drug benefits legislation and their impact on FDA final rules regarding generic drug approvals under the Waxman-Hatch Act.
Finish The Fight: Patients Can Push PBM Reform Legislation Over the Finish Line | NCPA 2024
PBM reform legislation has progressed further in Congress than ever before.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Texas Sues Multiple PBMs, Drug Manufacturers Over Inflated Insulin Prices
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.
Keep Up With Policy Changes Affecting Independent Pharmacy
This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.
FTC Files Lawsuit Against ‘Big 3’ PBMs for Drug Price Inflation
In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.
How the Big 3 PBMs Utilize Various Market Strategies
To further understand PBM market concentration, researchers separately analyzed commercial insurance, Medicare Part D, and Medicaid managed care market strategies of the 3 biggest PBMs.